AnaptysBio (ANAB) Stock Price & Analysis
ANAB$46.25-1.52 -3.18%
Market cap$1.38BEnterprise value$1.25BRevenue (TTM)$191.57MMarket position—
Score
78
Bullish
Value
62
Quality
72
Growth
100
AI Analysis
SnapshotAnaptysBio mixes growth with a still-reasonable multiple — Growth 100/100 with P/E 7.3. Under the hood: P/E 7.3, plus revenue compounding ~219% annually over recent years.
Price History
Price: —
Fair value: —
—
P/E (TTM): —
Net Income (TTM): —
Score: —
—
Bullish (65+)Neutral (45–64)Bearish (<45)
Score Breakdown
Market percentile scores loading…
Value
62
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–
Growth
100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–
Quality
72
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–
Financial Summary
AnaptysBio, Inc. (ANAB) last printed $46.25. Equity value is $1.38B. Trailing earnings multiple 7.48. The revenue row is reported history. Targets and ratings are on the forecast page.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| $16.68M | $10M | $5M | $8M | $75M | $63.17M | $10.29M | $17.16M | $91.28M | $234.6M |
About
Company description is not on file.